leisure time -WSS

leisure time

author：entertainment 2025-10-01 04:45:02 - browse：5

Vivistim and Lead — A small Texas company is testing whether pairing vagus nerve stimulation with rehabilitation exercise can restore movement in people who have had a stroke. STAT/MicroTransponder, Inc.

Despite being forced by Hurricane Irma to close its outpatient facilities for several days, the Mayo Clinic in Jacksonville, Fla., is expected to forge ahead this month with a pivotal clinical trial testing whether an electrical implant can rewire the brains of stroke patients so they can use their arms and hands again.

If the patients who receive implants regain significantly more function than those who get only standard rehabilitation, it will show that stroke-damaged brain circuits can be bypassed like shorts in a circuit board, with healthy neurons coaxed into performing the job of those fried by stroke.

Although the results might not be make-or-break for the little 11-year-old Texas company sponsoring the trial (called MicroTransponder, the company’s also testing whether an electrical implant can alleviate tinnitus), there will be more evidence of whether “electroceuticals” — electrical stimuli tailored to treat diseases — work beyond their current use in controlling pain and a few other conditions or will fall short of the buzz surrounding them.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

WSS

Profiling embryos to choose those with higher IQs is almost a reality

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

Stories you might have missed in 2023: health, science, medicine

How faith leaders like me can help address America's obesity epidemic

Coercive sterilizations revealed by STAT prompt outrage

JPM pitch from hospitals? Revenue streams outside of patient care

hotspot

leisure time

knowledge

Moonlake's readout produced a cash windfall. Risks remain

Medicare Advantage coverage denials need scrutiny, senators say

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Pharma companies must ensure equitable access to obesity drugs

Hollywood unions extend contract negotiations for actors

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

State Dept. review finds Biden bears some blame for Afghanistan failures

STAT Virtual Event: JPM Recap, Live!

In age of alternative facts, a scholarly course on calling out crap

Fauci's latest grilling in Congress: 9 hours, behind closed doors

explore

A preacher's new calling: Diversifying neuroscience research

Stories you might have missed in 2023: health, science, medicine

Medicare Advantage coverage denials need scrutiny, senators say

NIH tests clinical research in primary care with $30 million program

Boston Scientific acquires urology company Axonics for $3.7 billion

Medical device trials still don't enroll enough women, study finds

hotspot

focus

leisure time

explore